A 10-year cohort study of 175 primary gastrointestinal lymphoma cases in Thailand: clinical features and outcomes in the immunochemotherapy era

CONCLUSIONS: The stomach was the most common site of lymphoma involvement in the GI tract, with DLBCL accounting for the highest proportion of those patients. The long-term survival outcome was significantly improved in patients with good performance status and rituximab exposure. Trial registrationNot applicable.PMID:33618613 | DOI:10.1080/16078454.2021.1889160

Source: Hematology - February 23, 2021 Category: Hematology Authors: Weerapat Owattanapanich Theera Ruchutrakool Tawatchai Pongpruttipan Monthira Maneerattanaporn Source Type: research